What prognostic information does flow cytometry provide in canine B-cell lymphoma?
Veterinary Evidence
|April 20, 2026
Summary
Flow cytometry offers valuable prognostic insights for canine B-cell lymphoma. Specific markers like CD25 and Ki67 show promise for predicting outcomes, aiding clinical decisions.
Area of Science:
- Veterinary Oncology
- Immunology
Background:
- Canine B-cell lymphoma presents a significant oncological challenge.
- Accurate prognostic indicators are crucial for effective treatment planning.
Purpose of the Study:
- To evaluate the prognostic utility of flow cytometry in canine B-cell lymphoma.
- To identify specific flow cytometry markers that correlate with patient outcomes.
Main Methods:
- A critical review of twelve cohort studies was conducted.
- Flow cytometry was used to assess various cellular markers and parameters.
Main Results:
- Percentage expression of CD25 and Ki67 cellular markers shows promising prognostic value.
- Flow cytometry is useful for assessing bone marrow infiltration and its prognostic implications.
- Evidence suggests prognostic value for class II MHC, CTLA-4, lymphocyte/monocyte ratios, and T/B cell ratios.
Conclusions:
- Flow cytometry provides useful prognostic measures for canine B-cell lymphoma, requiring further validation for routine use.
- CD25 and Ki67 expression are promising indicators needing clinical translation.
- Bone marrow infiltration assessment via flow cytometry is valuable, but other markers require further investigation.
